Evidence map›Paper›PMID 40309531›Full record

ArticleNigerian medical journal : journal of the Nigeria Medical Association

Is there Co-infection of Influenza and Covid-19 in Jos, North Central Nigeria?

Nathan Yakubu Shehu, Mark Ojogba Okolo, Emmanuel Ameh Ameh, Daniel Geofrey Thankgod, Oluwatoyin Ruth Morenikeji, Ferdinand Ibu Ogbaji, Dung Davou Pam, Filibus Danjuma Dami, Pam Dachung Luka

Abstract read
In one paragraph

Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nathan Yakubu ShehuThe West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Mark Ojogba OkoloDepartment of Microbiology, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Emmanuel Ameh AmehThe West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Daniel Geofrey ThankgodBiotechnology Centre, National Veterinary Research Institute, Vom, Plateau State, Nigeria.
Oluwatoyin Ruth MorenikejiThe West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Ferdinand Ibu OgbajiDepartment of Community Medicine, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Dung Davou PamDepartment of Zoology, University of Jos, Jos, Plateau State, Nigeria.
Filibus Danjuma DamiAP Leventis Ornithological Research Institute, University of Jos, Jos, Plateau State, Nigeria.
Pam Dachung LukaBiotechnology Centre, National Veterinary Research Institute, Vom, Plateau State, Nigeria.

Funding

West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN)D43TW012246 · FIC · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Nikos Vasilakis, Scott C Weaver · 2022 to 2026
$1.2M
FIC NIH HHS D43 TW012246NIAID NIH HHS U01 AI151801
6 · The paper itself

Abstract

Background: Influenza virus and severe acute respiratory syndrome virus-2 (SARS CoV-2) are known to cause respiratory disease in humans that may be fatal. They have caused epidemics and constitute significant public health challenges because of their ability to spread and cause severe disease. Co-infection with both viruses has been shown to increase the odds of fatality among affected patients. Our study aimed to investigate co-infection with influenza among patients with coronavirus disease-2019 (COVID-19) in Jos, Plateau State. Methodology: We carried out a cross-sectional study using stored nasopharyngeal and oropharyngeal samples of patients diagnosed with COVID-19 using GeneXpert. The samples were collected at our institution and stored at -80 °C. The samples were analysed for influenza co-infection using real-time reverse transcriptase polymerase chain reaction. Results: Two-hundred-and-forty-one (241) stored samples of patients diagnosed with COVID-19 were analysed. None of the samples tested positive for the influenza virus. Conclusion: We found no case of influenza and SARS-CoV-2 co-infection among the patients studied. This suggests that the prevalence of influenza virus infection may be low in our setting and partly explains the relatively benign outcome of SARS-CoV-2 infections in our region.

Indexed as

Co-infectionEpidemicsInfluenza, HumanNigeriaSARS-CoV-2

Identifiers

PMID40309531
PMCPMC12038622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.